<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    wjcd
   </journal-id>
   <journal-title-group>
    <journal-title>
     World Journal of Cardiovascular Diseases
    </journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2164-5329
   </issn>
   <issn publication-format="print">
    2164-5337
   </issn>
   <publisher>
    <publisher-name>
     Scientific Research Publishing
    </publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">
    10.4236/wjcd.2025.1511051
   </article-id>
   <article-id pub-id-type="publisher-id">
    wjcd-147502
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Articles
     </subject>
    </subj-group>
    <subj-group subj-group-type="Discipline-v2">
     <subject>
      Medicine 
     </subject>
     <subject>
       Healthcare
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    Impact of Cardiovascular Rehabilitation on the Functional Capacity of Patients with Heart Failure: A Cohort Study at Yaoundé General Hospital, Cameroon
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Hermann Nestor Tsague
      </surname>
      <given-names>
       Kengni
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Djibrilla
      </surname>
      <given-names>
       Siddikatou
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff4"> 
      <sup>4</sup>
     </xref> 
     <xref ref-type="aff" rid="aff5"> 
      <sup>5</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Marie Solange Ndom
      </surname>
      <given-names>
       Ebongue
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff4"> 
      <sup>4</sup>
     </xref> 
     <xref ref-type="aff" rid="aff5"> 
      <sup>5</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Laurence Carole Ngo
      </surname>
      <given-names>
       Yon
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Nafissatou Panchut
      </surname>
      <given-names>
       Nsangou
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Eczechias Ndoyou
      </surname>
      <given-names>
       Ndjamakou
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff4"> 
      <sup>4</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Christelle Menoue
      </surname>
      <given-names>
       Djimafo
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Sylvanie Tchuinkam
      </surname>
      <given-names>
       Tchoubat
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Germaine Christelle Tsafack
      </surname>
      <given-names>
       Soefack
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Edgar Mandeng Ma
      </surname>
      <given-names>
       Linwa
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff6"> 
      <sup>6</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Elysée Claude Bika
      </surname>
      <given-names>
       Léle
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff7"> 
      <sup>7</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Alain Patrick
      </surname>
      <given-names>
       Menanga
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Félicité
      </surname>
      <given-names>
       Kamdem
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff4"> 
      <sup>4</sup>
     </xref> 
     <xref ref-type="aff" rid="aff8"> 
      <sup>8</sup>
     </xref>
    </contrib>
   </contrib-group> 
   <aff id="aff1">
    <addr-line>
     aFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon
    </addr-line> 
   </aff> 
   <aff id="aff2">
    <addr-line>
     aYaoundé General Hospital, Yaoundé, Cameroon
    </addr-line> 
   </aff> 
   <aff id="aff3">
    <addr-line>
     aCardiac Prevention Foundation, Douala, Cameroon
    </addr-line> 
   </aff> 
   <aff id="aff4">
    <addr-line>
     aFaculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon
    </addr-line> 
   </aff> 
   <aff id="aff5">
    <addr-line>
     aLaquintinie Douala Hospital, Douala, Cameroon
    </addr-line> 
   </aff> 
   <aff id="aff6">
    <addr-line>
     aFaculty of Health Sciences (FHS), University of Buea, Buea, Cameroon
    </addr-line> 
   </aff> 
   <aff id="aff7">
    <addr-line>
     aFaculty of Sciences, University of Douala, Douala, Cameroon
    </addr-line> 
   </aff> 
   <aff id="aff8">
    <addr-line>
     aDouala General Hospital, Douala, Cameroon
    </addr-line> 
   </aff> 
   <pub-date pub-type="epub">
    <day>
     03
    </day> 
    <month>
     11
    </month>
    <year>
     2025
    </year>
   </pub-date> 
   <volume>
    15
   </volume> 
   <issue>
    11
   </issue>
   <fpage>
    581
   </fpage>
   <lpage>
    594
   </lpage>
   <permissions>
    <copyright-statement>
     © Copyright 2014 by authors and Scientific Research Publishing Inc. 
    </copyright-statement>
    <copyright-year>
     2014
    </copyright-year>
    <license>
     <license-p>
      This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/
     </license-p>
    </license>
   </permissions>
   <abstract>
    <b>Background:</b> Cardiovascular rehabilitation (CR) enhances the functional capacity of patients with heart failure (HF), but its effectiveness remains understudied in low-resource settings such as Cameroon. This study aimed to evaluate the impact of CR on the functional capacity of HF patients at Yaoundé General Hospital (YGH). 
    <b>Methods:</b> A mixed retrospective and prospective cohort study was conducted at the Cardiovascular and Metabolic Rehabilitation Unit (CMRU) of YGH from February 2024 to May 2025. It included adults (≥21 years) diagnosed with HF according to the 2021 ESC criteria, who completed at least 10 CR sessions. The primary outcome was 6-minute walk test (6 MWT) distance. Secondary outcomes included VO
    <sub>2</sub>max estimated from 6 MWT (VO
    <sub>2</sub>max_6 MWT = distance × 0.1 + 3.5; the most objective VO
    <sub>2</sub>max estimate), VO
    <sub>2</sub>max estimated from the Duke Activity Status Index (DASI) questionnaire (VO
    <sub>2</sub>max_DASI = 0.43 × DASI + 9.6), Metabolic Equivalents (METs), and DASI score. These functional parameters were assessed before and after CR, and factors associated with changes (delta) in outcomes post CR were identified via linear regression. 
    <b>Results:</b> Thirty-three patients (mean age 59 ± 12 years; 60.6% male) were included. CR significantly improved 6 MWT distance (456 to 571 m), VO
    <sub>2</sub>max_6 MWT (11.02 to 13.02 mL/kg/min), VO
    <sub>2</sub>max_DASI (15.7 to 22.3 mL/kg/min), METs (5.08 to 8.6), and DASI score (13.3 to 29.5) (all p &lt; 0.001). Reductions in resting heart rate and systolic blood pressure, as well as improvements in dyspnoea (100% NYHA stage I post-CR), were also observed. Older age was associated with less improvement in VO
    <sub>2</sub>max_DASI, while higher baseline heart rate and a greater number of sessions were linked to better 6 MWT performance. 
    <b>Conclusion:</b> CR significantly improves functional capacity and haemodynamic parameters in HF patients in a low-resource setting. Integrating CR into universal health coverage and tailoring programmes for older patients could optimise outcomes.
   </abstract>
   <kwd-group> 
    <kwd>
     Cardiovascular Rehabilitation
    </kwd> 
    <kwd>
      Heart Failure
    </kwd> 
    <kwd>
      Functional Capacity
    </kwd> 
    <kwd>
      Cameroon
    </kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <sec id="s1">
   <title>1. Introduction</title>
   <p>Cardiovascular diseases (CVDs), the leading global cause of death with 19.8 million annual fatalities (32% of total mortality), include heart failure (HF) as a major burden in sub-Saharan Africa, where hospital prevalence reaches 12.0% in Sudan, 17.6% in Burkina Faso, 28.6% in Togo, and 30% in Cameroon, affecting 1% - 3% of the global adult population with a stable incidence of 1 - 20 cases per 1000 person-years, an annual cost of €25,500 per patient, and disproportionately impacting younger, often uninsured and less-educated individuals who commonly present in advanced New York Heart Association (NYHA) functional class IV <xref ref-type="bibr" rid="scirp.147502-1">
     [1]
    </xref>-<xref ref-type="bibr" rid="scirp.147502-3">
     [3]
    </xref>. The burden of HF in SSA is rising, with in-hospital mortality ranging from 3.7% - 19.0% <xref ref-type="bibr" rid="scirp.147502-4">
     [4]
    </xref>.</p>
   <p>HF leads to progressive physical deconditioning, impairing functional capacity and quality of life <xref ref-type="bibr" rid="scirp.147502-5">
     [5]
    </xref>. In a Cameroonian cohort, 54% of patients had moderate daily physical activity, 45% had low activity, and approximately 39.2% exhibited impaired physical fitness associated with obesity, low physical activity, and non-adherence to treatment, negatively affecting their quality of life <xref ref-type="bibr" rid="scirp.147502-6">
     [6]
    </xref>. Despite reduced mortality from medical treatments, morbidity due to deconditioning persists, increasing rehospitalisations and socioeconomic costs <xref ref-type="bibr" rid="scirp.147502-7">
     [7]
    </xref>.</p>
   <p>Cardiovascular rehabilitation (CR), defined by the WHO as a set of activities aimed at optimising physical, mental, and social conditions <xref ref-type="bibr" rid="scirp.147502-8">
     [8]
    </xref>, improves functional capacity, reduces hospitalisations, and promotes healthy lifestyle adoption <xref ref-type="bibr" rid="scirp.147502-9">
     [9]
    </xref>. However, in SSA, CR remains underutilised due to a lack of infrastructure, trained personnel, and awareness <xref ref-type="bibr" rid="scirp.147502-10">
     [10]
    </xref> <xref ref-type="bibr" rid="scirp.147502-11">
     [11]
    </xref>. Yaoundé General Hospital (YGH), a leading teaching hospital, established its Cardiovascular and Metabolic Rehabilitation Unit (CMRU) in February 2024, a pioneering initiative for managing HF patients in a resource-constrained setting. This study aims to: 1) describe the sociodemographic, clinical, and therapeutic profiles of HF patients; 2) compare their functional capacity before and after CR; and 3) identify determinants of changes in functional capacity. These findings could inform public health policies to integrate CR into universal health coverage, reducing access inequalities and contributing to the Sustainable Development Goals by 2030 <xref ref-type="bibr" rid="scirp.147502-12">
     [12]
    </xref>.</p>
  </sec><sec id="s2">
   <title>2. Methodology</title>
   <sec id="s2_1">
    <title>2.1. Study Design</title>
    <p>An analytical cohort study with retrospective and prospective components was conducted to assess the impact of CR on the functional capacity of HF patients at YGH.</p>
   </sec>
   <sec id="s2_2">
    <title>2.2. Setting and Study Period</title>
    <p>The study was conducted at the CMRU of YGH, located in Yaoundé, Cameroon, in a 25 m<sup>2</sup> room equipped with treadmills, cycle ergometers, a muscle-strengthening device, an electrocardiograph, and an echocardiograph. The unit, managed by two cardiologists, one general practitioner, and one nurse, serves approximately 10 patients monthly. The study spanned February 2024 to May 2025, with retrospective recruitment (February 2024-January 2025) and prospective recruitment (February-May 2025). Patients were followed for up to 4 weeks post-CR to assess outcomes and complications.</p>
   </sec>
   <sec id="s2_3">
    <title>2.3. Participants</title>
    <p>A consecutive non-probability sampling included all eligible patients.</p>
   </sec>
   <sec id="s2_4">
    <title>2.4. Variables</title>
    <p>HF types were operationally defined as: “Left-sided HF” (predominant left ventricular dysfunction without clinical signs of systemic congestion) and “Congestive HF” (biventricular dysfunction with clinical signs of systemic congestion, e.g., peripheral oedema, jugular venous distension). These categories were not mutually exclusive, as some patients with left-sided HF may progress to congestive features.</p>
   </sec>
   <sec id="s2_5">
    <title>2.5. Data Sources and Measurements</title>
   </sec>
   <sec id="s2_6">
    <title>2.6. CR Procedure</title>
    <p>The CR programme (10 - 25 sessions, 3 - 10 weeks, 2 - 3 sessions/week, 60 min) included:</p>
    <p>Sessions, supervised by a cardiologist or nurse, included therapeutic education. Contraindications were monitored via Electrocardiography.</p>
   </sec>
   <sec id="s2_7">
    <title>2.7. Bias</title>
    <p>Consecutive sampling minimised selection bias. Standardised protocols reduced information bias, despite occasional incomplete retrospective records. Linear regression controlled for confounders (age, sex, CVRF). Patients lost to follow-up were excluded, with reasons documented.</p>
   </sec>
   <sec id="s2_8">
    <title>2.8. Sample Size</title>
    <p>The sample size was calculated a priori to detect a clinically meaningful improvement in the primary outcome (6-minute walk test [6 MWT] distance) of 36 m—the minimal important difference (MID) for stable chronic heart failure patients over 6 - 12 months, derived from a standard error of measurement (SEM) approach in two large cohorts <xref ref-type="bibr" rid="scirp.147502-14">
      [14]
     </xref>, assuming a standard deviation of 115 m (typical baseline SD in heart failure rehabilitation cohorts <xref ref-type="bibr" rid="scirp.147502-14">
      [14]
     </xref> <xref ref-type="bibr" rid="scirp.147502-15">
      [15]
     </xref>), using a paired t-test, α = 0.05, and 80% power. This yielded a minimum of n = 29 patients. Allowing for up to 15% attrition due to incomplete sessions or missing data, a recruitment target of n = 34 was set. The final sample of n = 33 met this requirement. Post-hoc power analysis confirmed &gt; 99.9% power to detect the observed improvement of 115 m (SD = 112 m). Analysis of factors associated with 6 MWT and VO<sub>2</sub>max_DASI (11 predictors) was suboptimal (ideal: 60 - 120 patients) <xref ref-type="bibr" rid="scirp.147502-16">
      [16]
     </xref>.</p>
   </sec>
   <sec id="s2_9">
    <title>2.9. Statistical Analysis</title>
    <p>Continuous variables (6 MWT distance, VO<sub>2</sub>max_6 MWT, VO<sub>2</sub>max_DASI, etc.) were expressed as means ± standard deviation. Data normality was tested using the Shapiro-Wilk test. Pre- and post-CR parameters were compared using the paired Student’s t-test for quantitative variables and McNemar’s test for qualitative variables. Multivariate linear regression identified determinants of aerobic capacity (VO<sub>2</sub>max_DASI, 6 MWT), with regression coefficients adjusted for age and sex. Missing data were not imputed; patients with incomplete data were excluded from specific analyses.</p>
   </sec>
   <sec id="s2_10">
    <title>2.10. Ethical Considerations</title>
    <p>The study was approved by the Ethics Committee of the University of Douala (Ref: 4796/CEI-UDo/03/2025) and YGH (Ref: 0301-25/HGY/DG/DPM/APM-AS). Informed consent was obtained in the prospective phase; a waiver was granted for the retrospective phase (anonymised data). Data were coded, securely stored, and used solely for research purposes.</p>
   </sec>
  </sec><sec id="s3">
   <title>3. Results</title>
   <sec id="s3_1">
    <title>3.1. Participant Characteristics</title>
    <p>Of 35 patients enrolled in CR at the CMRU from February 2024 to May 2025, 33 were included (23 retrospective, 10 prospective) after excluding 2 for &lt; 10 sessions, as shown in <xref ref-type="fig" rid="fig1">
      Figure 1
     </xref>. The mean age was 59 ± 12 years, with 60.6% male (M/F ratio: 1.54). <xref ref-type="table" rid="table1">
      Table 1
     </xref> and <xref ref-type="fig" rid="fig2">
      Figure 2
     </xref> present the sociodemographic, clinical, and therapeutic characteristics. Hypertension was the most common CVRF (54.5%). Hypertensive heart disease was the primary aetiology (36.4%). LVEF was &lt; 40% in 62.5% of patients (mean 37.6 ± 16.3%). Congestive HF predominated (63.6%), with a mean disease duration of 3.6 years. Loop diuretics (90.9%) and beta-blockers (87.9%) were the most used treatments; ARNi (9.1%) and SGLT2 inhibitors (18.2%) were less prescribed (<xref ref-type="fig" rid="fig2">
      Figure 2
     </xref>).</p>
   </sec>
   <sec id="s3_2">
    <title>3.2. CR Programme</title>
    <p>The mean time from HF diagnosis to CR initiation was 3.6 years. Patients completed 14.09 ± 4.3 sessions (10 - 25), with 60.6% attending three sessions per week, as reported in <xref ref-type="table" rid="table2">
      Table 2
     </xref>.</p>
    <fig id="fig1" position="float">
     <label>Figure 1</label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.147502-"></xref>Figure 1. Participant flow chart.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/1911708-rId13.jpeg?20251125025744" />
    </fig>
    <table-wrap id="table1">
     <label>
      <xref ref-type="table" rid="table1">
       Table 1
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.147502-"></xref>Table 1. Sociodemographic and clinical characteristics.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td aleft" width="50.92%"><p style="text-align:left">Characteristics</p></td> 
       <td class="custom-bottom-td acenter" width="26.80%"><p style="text-align:center">Frequency (N = 33)</p></td> 
       <td class="custom-bottom-td acenter" width="22.28%"><p style="text-align:center">%</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td aleft" width="50.92%"><p style="text-align:left">Age (years)</p></td> 
       <td class="custom-top-td acenter" width="26.80%"><p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="22.28%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">&lt;50</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">10</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">30.4</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">≥50</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">23</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">69.6</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Sex</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center"></p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Male</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">20</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">60.6</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Female</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">13</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">39.4</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Residence</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center"></p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Yaoundé</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">19</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">57.6</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Other Cameroonian cities</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">11</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">33.3</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Abroad (Chad-N’Djamena)</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">3</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">9.1</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Comorbidities</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center"></p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Hypertension</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">18</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">54.5</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Alcoholism</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">16</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">48.5</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Dyslipidaemia</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">14</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">42.4</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Obesity</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">11</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">33.3</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Sedentary lifestyle</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">11</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">33.3</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Smoking</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">10</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">30.3</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Diabetes</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">6</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">18.2</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Gout</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">4</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">12.1</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Heart Failure (HF) Aetiology</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center"></p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Hypertensive heart disease</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">12</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">36.4</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Ischaemic heart disease</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">9</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">27.3</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Dilated cardiomyopathy</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">7</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">21.2</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Valvular heart disease</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">4</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">12.1</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Peripartum cardiomyopathy</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">1</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">3.0</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Left Ventricular Ejection Fraction</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center"></p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">&lt;40%</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">20</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">62.5</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">40% - 49%</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">3</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">9.4</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">≥50%</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">9</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">28.1</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">HF Type</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center"></p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Left-sided HF</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">12</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">36.4</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="50.92%"><p style="text-align:left">Congestive HF</p></td> 
       <td class="acenter" width="26.80%"><p style="text-align:center">21</p></td> 
       <td class="acenter" width="22.28%"><p style="text-align:center">63.6</p></td> 
      </tr> 
     </table>
    </table-wrap>
    <fig id="fig2" position="float">
     <label>Figure 2</label>
     <caption>
      <title>ARNi: Angiotensin receptor-neprilysin inhibitors; BB: Beta-blockers; ARB: Angiotensin II receptor blockers; MRA: Mineralocorticoid receptor antagonists; SGLT2i: Sodium-glucose cotransporter 2 inhibitors; ACEi: Angiotensin-converting enzyme inhibitors.<xref ref-type="bibr" rid="scirp.147502-"></xref>Figure 2. Distribution of patients by treatment received.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/1911708-rId14.jpeg?20251125025744" />
    </fig>
    <table-wrap id="table2">
     <label>
      <xref ref-type="table" rid="table2">
       Table 2
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.147502-"></xref>Table 2. Number and frequency of CR sessions.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td aleft" width="48.09%"><p style="text-align:left">Variables</p></td> 
       <td class="custom-bottom-td acenter" width="31.32%"><p style="text-align:center">Frequency (N = 33)</p></td> 
       <td class="custom-bottom-td acenter" width="20.59%"><p style="text-align:center">%</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td aleft" width="48.09%"><p style="text-align:left">Number of Sessions</p></td> 
       <td class="custom-top-td acenter" width="31.32%"><p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="20.59%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="48.09%"><p style="text-align:left">10</p></td> 
       <td class="acenter" width="31.32%"><p style="text-align:center">8</p></td> 
       <td class="acenter" width="20.59%"><p style="text-align:center">24.2</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="48.09%"><p style="text-align:left">11 - 19</p></td> 
       <td class="acenter" width="31.32%"><p style="text-align:center">17</p></td> 
       <td class="acenter" width="20.59%"><p style="text-align:center">51.5</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="48.09%"><p style="text-align:left">≥20</p></td> 
       <td class="acenter" width="31.32%"><p style="text-align:center">8</p></td> 
       <td class="acenter" width="20.59%"><p style="text-align:center">24.2</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="48.09%"><p style="text-align:left">Frequency (days/week)</p></td> 
       <td class="acenter" width="31.32%"><p style="text-align:center"></p></td> 
       <td class="acenter" width="20.59%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="48.09%"><p style="text-align:left">2</p></td> 
       <td class="acenter" width="31.32%"><p style="text-align:center">13</p></td> 
       <td class="acenter" width="20.59%"><p style="text-align:center">39.4</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="48.09%"><p style="text-align:left">3</p></td> 
       <td class="acenter" width="31.32%"><p style="text-align:center">20</p></td> 
       <td class="acenter" width="20.59%"><p style="text-align:center">60.6</p></td> 
      </tr> 
     </table>
    </table-wrap>
   </sec>
   <sec id="s3_3">
    <title>3.3. Changes in Physiological and Clinical Parameters</title>
    <p>
     <xref ref-type="table" rid="table3">
      Table 3
     </xref> shows significant reductions in haemodynamic parameters and BMI, alongside a substantial increase in LVEF (+22.9%, p &lt; 0.001). Significant improvements (p &lt; 0.001) were observed in all cardiorespiratory fitness and rehabilitation parameters. The greatest improvement in cardiorespiratory fitness was for VO<sub>2</sub>max_DASI (+42.0%), while 6 MWT distance increased by +25.2% and VO<sub>2</sub>max_6 MWT (the most objective VO<sub>2</sub>max measure) by +18.1%. Maximal workload showed the largest</p>
    <table-wrap id="table3">
     <label>
      <xref ref-type="table" rid="table3">
       Table 3
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.147502-"></xref>Table 3. Haemodynamic and clinical changes.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter" width="41.75%"><p style="text-align:center">Variable</p></td> 
       <td class="custom-bottom-td acenter" width="16.23%"><p style="text-align:center">Pre-CR</p></td> 
       <td class="custom-bottom-td acenter" width="17.15%"><p style="text-align:center">Post-CR</p></td> 
       <td class="custom-bottom-td acenter" width="12.92%"><p style="text-align:center">Δ (%)</p></td> 
       <td class="custom-bottom-td acenter" width="11.94%"><p style="text-align:center">p</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="41.75%"><p style="text-align:center">Resting HR (bpm)</p></td> 
       <td class="custom-top-td acenter" width="16.23%"><p style="text-align:center">76 ± 13</p></td> 
       <td class="custom-top-td acenter" width="17.15%"><p style="text-align:center">70 ± 10</p></td> 
       <td class="custom-top-td acenter" width="12.92%"><p style="text-align:center">–7.9%</p></td> 
       <td class="custom-top-td acenter" width="11.94%"><p style="text-align:center">0.001</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="41.75%"><p style="text-align:center">Resting SBP (mmHg)</p></td> 
       <td class="acenter" width="16.23%"><p style="text-align:center">124 ± 17</p></td> 
       <td class="acenter" width="17.15%"><p style="text-align:center">117 ± 11</p></td> 
       <td class="acenter" width="12.92%"><p style="text-align:center">–5.6%</p></td> 
       <td class="acenter" width="11.94%"><p style="text-align:center">0.004</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="41.75%"><p style="text-align:center">Resting DBP (mmHg)</p></td> 
       <td class="acenter" width="16.23%"><p style="text-align:center">76 ± 11</p></td> 
       <td class="acenter" width="17.15%"><p style="text-align:center">71 ± 8</p></td> 
       <td class="acenter" width="12.92%"><p style="text-align:center">–6.6%</p></td> 
       <td class="acenter" width="11.94%"><p style="text-align:center">0.008</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="41.75%"><p style="text-align:center">BMI (kg/m<sup>2</sup>)</p></td> 
       <td class="acenter" width="16.23%"><p style="text-align:center">28.7 ± 10.2</p></td> 
       <td class="acenter" width="17.15%"><p style="text-align:center">28.0 ± 9.9</p></td> 
       <td class="acenter" width="12.92%"><p style="text-align:center">–2.4%</p></td> 
       <td class="acenter" width="11.94%"><p style="text-align:center">0.025</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="41.75%"><p style="text-align:center">LVEF (%)</p></td> 
       <td class="acenter" width="16.23%"><p style="text-align:center">37.6 ± 16.3</p></td> 
       <td class="acenter" width="17.15%"><p style="text-align:center">46.2 ± 13.4</p></td> 
       <td class="acenter" width="12.92%"><p style="text-align:center">+22.9%</p></td> 
       <td class="acenter" width="11.94%"><p style="text-align:center">&lt;0.001</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="41.75%"><p style="text-align:center">6 MWT (m)</p></td> 
       <td class="acenter" width="16.23%"><p style="text-align:center">456 ± 124</p></td> 
       <td class="acenter" width="17.15%"><p style="text-align:center">571 ± 101</p></td> 
       <td class="acenter" width="12.92%"><p style="text-align:center">+25.2%</p></td> 
       <td class="acenter" width="11.94%"><p style="text-align:center">&lt;0.001</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="41.75%"><p style="text-align:center">VO<sub>2</sub>max 6 MWT (mL/kg/min)</p></td> 
       <td class="acenter" width="16.23%"><p style="text-align:center">11.02 ± 4.3</p></td> 
       <td class="acenter" width="17.15%"><p style="text-align:center">13.02 ± 4.5</p></td> 
       <td class="acenter" width="12.92%"><p style="text-align:center">+18.1%</p></td> 
       <td class="acenter" width="11.94%"><p style="text-align:center">&lt;0.001</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="41.75%"><p style="text-align:center">VO<sub>2</sub>max DASI (mL/kg/min)</p></td> 
       <td class="acenter" width="16.23%"><p style="text-align:center">15.7 ± 4.3</p></td> 
       <td class="acenter" width="17.15%"><p style="text-align:center">22.3 ± 4.5</p></td> 
       <td class="acenter" width="12.92%"><p style="text-align:center">+42.0%</p></td> 
       <td class="acenter" width="11.94%"><p style="text-align:center">&lt;0.001</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="41.75%"><p style="text-align:center">METs</p></td> 
       <td class="acenter" width="16.23%"><p style="text-align:center">5.08 ± 1.86</p></td> 
       <td class="acenter" width="17.15%"><p style="text-align:center">8.6 ± 2.2</p></td> 
       <td class="acenter" width="12.92%"><p style="text-align:center">+69.3%</p></td> 
       <td class="acenter" width="11.94%"><p style="text-align:center">&lt;0.001</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="41.75%"><p style="text-align:center">Peak Exercise Level</p></td> 
       <td class="acenter" width="16.23%"><p style="text-align:center">2.79 ± 1.11</p></td> 
       <td class="acenter" width="17.15%"><p style="text-align:center">4.42 ± 0.83</p></td> 
       <td class="acenter" width="12.92%"><p style="text-align:center">+58.4%</p></td> 
       <td class="acenter" width="11.94%"><p style="text-align:center">&lt;0.001</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="41.75%"><p style="text-align:center">Exercise Duration (min)</p></td> 
       <td class="acenter" width="16.23%"><p style="text-align:center">8.5 ± 3.3</p></td> 
       <td class="acenter" width="17.15%"><p style="text-align:center">13.27 ± 2.49</p></td> 
       <td class="acenter" width="12.92%"><p style="text-align:center">+56.1%</p></td> 
       <td class="acenter" width="11.94%"><p style="text-align:center">&lt;0.001</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="41.75%"><p style="text-align:center">Maximal Workload (Watts)</p></td> 
       <td class="acenter" width="16.23%"><p style="text-align:center">25.0 ± 12.1</p></td> 
       <td class="acenter" width="17.15%"><p style="text-align:center">42.9 ± 12.8</p></td> 
       <td class="acenter" width="12.92%"><p style="text-align:center">+71.6%</p></td> 
       <td class="acenter" width="11.94%"><p style="text-align:center">&lt;0.001</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="41.75%"><p style="text-align:center">Fatigue</p></td> 
       <td class="acenter" width="16.23%"><p style="text-align:center">32 (97%)</p></td> 
       <td class="acenter" width="17.15%"><p style="text-align:center">2 (6.1%)</p></td> 
       <td class="acenter" width="12.92%"><p style="text-align:center">–90.9%</p></td> 
       <td class="acenter" width="11.94%"><p style="text-align:center">&lt;0.001</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="41.75%"><p style="text-align:center">Dyspnoea NYHA II-III</p></td> 
       <td class="acenter" width="16.23%"><p style="text-align:center">33 (100%)</p></td> 
       <td class="acenter" width="17.15%"><p style="text-align:center">0</p></td> 
       <td class="acenter" width="12.92%"><p style="text-align:center">–100%</p></td> 
       <td class="acenter" width="11.94%"><p style="text-align:center">&lt;0.001</p></td> 
      </tr> 
     </table>
    </table-wrap>
    <p>Δ = Change from pre CR to post CR; BMI = Body Mass Index; DASI = Duke Activity Status Index; DBP = Diastolic Blood Pressure; HR = Heart rate; LVEF = Left Ventricular Ejection Fraction; METs = Metabolic Equivalents, NYHA = New York Heart Association; SBP = Systolic Blood Pressure; VO<sub>2</sub>max = highest oxygen uptake during physical work at sea level; 6 MWT = 6 Minute Walking Test.</p>
    <p>increase among rehabilitation parameters (+71.6%). Clinically, of 32 patients, only two reported fatigue post-CR. All patients had NYHA stage II or III dyspnoea at baseline, but all were staged NYHA I post-CR.</p>
   </sec>
   <sec id="s3_4">
    <title>3.4. Determinants of Functional Capacity Changes</title>
    <p>Older age was associated with less improvement in VO<sub>2</sub>max_DASI (β = –0.23, p &lt; 0.001). Longer HF duration (β = 7.02, p = 0.003), higher baseline resting HR (β = 3.33, p = 0.007), and more sessions (β = 5.44, p = 0.033) were linked to greater 6 MWT distance improvement. Male sex predicted less 6 MWT improvement (β = –58.58, p = 0.013), as shown in <xref ref-type="table" rid="table4">
      Table 4
     </xref>.</p>
    <table-wrap id="table4">
     <label>
      <xref ref-type="table" rid="table4">
       Table 4
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.147502-"></xref>Table 4. Determinants of changes in VO<sub>2</sub>max_DASI and 6 MWT distance.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td rowspan="2" class="acenter" width="28.99%"><p style="text-align:center">Parameters</p></td> 
       <td class="custom-bottom-td acenter" width="35.50%" colspan="2"><p style="text-align:center">VO<sub>2</sub>max_DASI</p></td> 
       <td class="custom-bottom-td acenter" width="35.51%" colspan="2"><p style="text-align:center">6 MWT Distance</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td custom-top-td acenter" width="17.74%"><p style="text-align:center">β ± SE</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="17.76%"><p style="text-align:center">p</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="17.76%"><p style="text-align:center">β ± SE</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="17.76%"><p style="text-align:center">p</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="28.99%"><p style="text-align:center">Age (years)</p></td> 
       <td class="custom-top-td acenter" width="17.74%"><p style="text-align:center">–0.23 ± 0.06</p></td> 
       <td class="custom-top-td acenter" width="17.76%"><p style="text-align:center">&lt;0.001</p></td> 
       <td class="custom-top-td acenter" width="17.76%"><p style="text-align:center">0.24 ± 1.09</p></td> 
       <td class="custom-top-td acenter" width="17.76%"><p style="text-align:center">0.828</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="28.99%"><p style="text-align:center">HF Duration (years)</p></td> 
       <td class="acenter" width="17.74%"><p style="text-align:center">0.02 ± 0.18</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.924</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">7.02 ± 2.39</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.003</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="28.99%"><p style="text-align:center">Sex (Female)</p></td> 
       <td class="acenter" width="17.74%"><p style="text-align:center">–1.01 ± 1.62</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.534</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">–58.58 ± 23.65</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.013</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="28.99%"><p style="text-align:center">HF Type (Global)</p></td> 
       <td class="acenter" width="17.74%"><p style="text-align:center">0.46 ± 1.65</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.781</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">32.22 ± 26.91</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.231</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="28.99%"><p style="text-align:center">Hypertension (Yes)</p></td> 
       <td class="acenter" width="17.74%"><p style="text-align:center">–0.99 ± 1.58</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.531</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">–29.15 ± 25.45</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.252</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="28.99%"><p style="text-align:center">Dyslipidaemia (Yes)</p></td> 
       <td class="acenter" width="17.74%"><p style="text-align:center">–1.19 ± 1.6</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.457</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">–40.56 ± 25.81</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.116</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="28.99%"><p style="text-align:center">Resting SBP (mmHg)</p></td> 
       <td class="acenter" width="17.74%"><p style="text-align:center">0.02 ± 0.05</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.68</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">–0.13 ± 0.79</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.87</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="28.99%"><p style="text-align:center">Resting DBP (mmHg)</p></td> 
       <td class="acenter" width="17.74%"><p style="text-align:center">0.04 ± 0.08</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.6</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.77 ± 1.19</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.517</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="28.99%"><p style="text-align:center">Resting HR (bpm)</p></td> 
       <td class="acenter" width="17.74%"><p style="text-align:center">–0.04 ± 0.07</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.523</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">3.33 ± 1.24</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.007</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="28.99%"><p style="text-align:center">LVEF</p></td> 
       <td class="acenter" width="17.74%"><p style="text-align:center">0.03 ± 0.05</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.526</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">1.36 ± 1.18</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.250</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="28.99%"><p style="text-align:center">BMI (kg/m<sup>2</sup>)</p></td> 
       <td class="acenter" width="17.74%"><p style="text-align:center">0.00 ± 0.08</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.97</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">1.74 ± 2.26</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.44</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="28.99%"><p style="text-align:center">Number of Sessions</p></td> 
       <td class="acenter" width="17.74%"><p style="text-align:center">–0.19 ± 0.17</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.284</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">5.44 ± 2.56</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.033</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="28.99%"><p style="text-align:center">Frequency (/week)</p></td> 
       <td class="acenter" width="17.74%"><p style="text-align:center">0.44 ± 1.43</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.759</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">–13.21 ± 22.84</p></td> 
       <td class="acenter" width="17.76%"><p style="text-align:center">0.563</p></td> 
      </tr> 
     </table>
    </table-wrap>
    <p>β = regression coefficient; DBP = Diastolic Blood Pressure; HF = Heart Failure; HR = Heart rate; LVEF = Left Ventricular Ejection Fraction; SE = Standard Error; SBP = Systolic Blood Pressure; VO<sub>2</sub>max = highest oxygen uptake during physical work at sea level; 6 MWT = 6 Minute Walking Test.</p>
   </sec>
   <sec id="s3_5">
    <title>3.5. Complications and Follow-Up</title>
    <p>No deaths occurred during CR. One readmission for dyspnoea was noted within 4 weeks post-CR, with no deaths reported.</p>
   </sec>
  </sec><sec id="s4">
   <title>4. Discussion</title>
   <p>This cohort study, conducted at YGH’s CMRU from February 2024 to May 2025, assessed the impact of CR on 33 HF patients. Results demonstrate that CR significantly enhances cardiorespiratory fitness, improves haemodynamic profiles, and reduces dyspnoea in all patients. Post-CR VO<sub>2</sub>max_DASI was significantly associated with age, while 6 MWT distance was linked to disease duration, sex, baseline resting HR, and number of sessions.</p>
   <p>This study aligns with international literature confirming CR benefits for HF patients. A systematic review by Sadek et al. (2021) showed that structured aerobic exercise in CR significantly improves VO<sub>2</sub>max and LVEF in chronic HF patients <xref ref-type="bibr" rid="scirp.147502-17">
     [17]
    </xref>. For instance, Wissløff et al. (2007) in Norway reported VO<sub>2</sub>max increases from 13 ± 1.6 to 19 ± 2.1 mL/kg/min (p &lt; 0.01) and LVEF from 28% ± 7.3% to 38% ± 9.8% (p &lt; 0.01) with intensive CR, while less intensive protocols showed smaller improvements (VO<sub>2</sub>max: 13 ± 1.1 to 14.9 ± 0.9 mL/kg/min, p &lt; 0.01; LVEF: 32.8% ± 4.8% to 33.5% ± 5.7%, p &gt; 0.05) <xref ref-type="bibr" rid="scirp.147502-18">
     [18]
    </xref>. Our study reports comparable or superior improvements in a low-resource setting (6 MWT: +115 m; VO<sub>2</sub>max_6 MWT: +2.0 mL/kg/min; VO<sub>2</sub>max_DASI: +6.6 mL/kg/min; LVEF: +22.9%), highlighting CR’s efficacy despite modest infrastructure at YGH. The notable LVEF improvement (22.9%), rarely reported in SSA, may reflect the combined effect of session intensity (Borg scale 12 - 14) and therapeutic education, which potentially encouraged medication adherence (though not formally assessed in this study). However, the lack of a control group limits comparisons with randomised trials like those of Wissløff (2007) or Ellingsen (2017) <xref ref-type="bibr" rid="scirp.147502-18">
     [18]
    </xref> <xref ref-type="bibr" rid="scirp.147502-19">
     [19]
    </xref>.</p>
   <p>The significant improvements in functional capacity and haemodynamic parameters can be attributed to the YGH CMRU’s CR programme, combining aerobic exercises (treadmill, cycle ergometer), light muscle strengthening, and therapeutic education over 10–25 sessions (mean 14.09 ± 4.3), which optimised physical reconditioning and treatment adherence, as supported by the WHO <xref ref-type="bibr" rid="scirp.147502-8">
     [8]
    </xref>. LVEF improvement may stem from better adherence to pharmacological treatments (loop diuretics: 90.9%; beta-blockers: 87.9%), reinforced by therapeutic education at the CMRU, a mechanism noted by Tüner et al. (2025) in Türkiye <xref ref-type="bibr" rid="scirp.147502-20">
     [20]
    </xref>.</p>
   <p>Older age, limiting VO<sub>2</sub>max improvement (β = –0.23, p &lt; 0.001), reflects reduced functional reserve, as reported by other authors <xref ref-type="bibr" rid="scirp.147502-18">
     [18]
    </xref>-<xref ref-type="bibr" rid="scirp.147502-20">
     [20]
    </xref>. Greater 6 MWT improvement with more sessions (β = 5.44, p = 0.033) and higher baseline resting HR (β = 3.33, p = 0.007) re-emphasises the importance of session intensity and regularity, aligning with Sadek et al. (2021) <xref ref-type="bibr" rid="scirp.147502-17">
     [17]
    </xref>. The resolution of dyspnoea (97% NYHA stage I, p &lt; 0.001) may relate to improved physical fitness and reduced oxidative stress, though the lack of a control group limits causal attribution <xref ref-type="bibr" rid="scirp.147502-21">
     [21]
    </xref>-<xref ref-type="bibr" rid="scirp.147502-23">
     [23]
    </xref>.</p>
   <p>This study, among the first in Central Africa, reinforces CR’s feasibility in low-resource settings. Standardised tests ensure methodological robustness. However, the small sample size (n = 33) limits generalisability, and the absence of a control group complicates causal attribution. High CR costs and lack of health insurance (84.8% without coverage) may have affected adherence.</p>
  </sec><sec id="s5">
   <title>5. Conclusions</title>
   <p>CR significantly improves functional capacity and haemodynamic parameters in HF patients in Cameroon, despite a resource-constrained setting. These findings underscore the urgency of integrating CR into universal health coverage and developing tailored infrastructure. Personalising programmes for older patients and enhancing therapeutic education could optimise outcomes, contributing to reduced cardiovascular morbidity.</p>
   <p>What Is Known About This Topic?</p>
   <p>What This Study Adds</p>
  </sec><sec id="s6">
   <title>Acknowledgements</title>
   <p>The authors thank the administration of Yaoundé General Hospital for authorising this research. The authors also acknowledge the hospital staff and volunteers from the Cardiac Prevention Foundation for their collaboration, which facilitated data collection.</p>
  </sec><sec id="s7">
   <title>Data Availability</title>
   <p>Data supporting the study’s findings are available from the corresponding author (SD) upon reasonable request.</p>
  </sec><sec id="s8">
   <title>Ethical Approval</title>
   <p>The study was approved by the Ethics Committee of the University of Douala (Ref: 4796/CEI-UDo/03/2025) and YGH (Ref: 0301-25/HGY/DG/DPM/APM-AS). The requirement for informed consent was waived for the retrospective phase due to the use of anonymised secondary data. All procedures complied with applicable guidelines and regulations.</p>
  </sec><sec id="s9">
   <title>Author Contributions</title>
   <p>Study conception and design: TH, SD, NNE. Data collection: NNE. Data analysis and interpretation: NNE. Manuscript drafting: All authors. Final manuscript approval: All authors. KF supervised the study. SD and NNE had full access to all study data and took responsibility for data integrity and analysis accuracy. All authors agreed to submit the manuscript in its current form.</p>
  </sec>
 </body><back>
  <ref-list>
   <title>References</title>
   <ref id="scirp.147502-ref1">
    <label>1</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Gtif, I., Bouzid, F., Charfeddine, S., Abid, L. and Kharrat, N. (2021) Heart Failure Disease: An African Perspective. Archives of Cardiovascular Diseases, 114, 680-690. &gt;https://doi.org/10.1016/j.acvd.2021.07.001
    </mixed-citation>
   </ref>
   <ref id="scirp.147502-ref2">
    <label>2</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Savarese, G., Becher, P.M., Lund, L.H., Seferovic, P., Rosano, G.M.C. and Coats, A.J.S. (2022) Global Burden of Heart Failure: A Comprehensive and Updated Review of Epidemiology. Cardiovascular Research, 118, 3272-3287. &gt;https://doi.org/10.1093/cvr/cvac013
    </mixed-citation>
   </ref>
   <ref id="scirp.147502-ref3">
    <label>3</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Gallagher, J., McDonald, K., Ledwidge, M. and Watson, C.J. (2018) Heart Failure in Sub-Saharan Africa. Cardiac Failure Review, 4, 21-24. &gt;https://doi.org/10.15420/cfr.2018:4:1
    </mixed-citation>
   </ref>
   <ref id="scirp.147502-ref4">
    <label>4</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Siddikatou, D., Mandeng Ma Linwa, E., Ndobo, V., Nkoke, C., Mouliom, S., Ndom, M.S., et al. (2025) Heart Failure Outcomes in Sub-Saharan Africa: A Scoping Review of Recent Studies Conducted after the 2022 AHA/ACC/HFSA Guideline Release. BMC Cardiovascular Disorders, 25, Article No. 302. &gt;https://doi.org/10.1186/s12872-025-04756-y
    </mixed-citation>
   </ref>
   <ref id="scirp.147502-ref5">
    <label>5</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ruku, D.M., Shintya, L.A. and Chen, H.M. (2024) Relationship between Physical Performance and Health-Related Quality of Life in Patients with Heart Failure. REC: CardioClinics, 59, 177-183. &gt;https://doi.org/10.1016/j.rccl.2023.10.008
    </mixed-citation>
   </ref>
   <ref id="scirp.147502-ref6">
    <label>6</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Nganou-Gnindjio, C.N., Tankeu, A., Assomo Ndemba, P., Chatue Ngassi, M.N. and Kingue, S. (2021) Physical Activity and Deconditioning of Heart Failure’s Patients Followed at Two Yaoundé’s Hospitals Settings: A Cross-Sectional Study in Cameroon. Annales de Cardiologie et d’Angéiologie, 70, 199-202. &gt;https://doi.org/10.1016/j.ancard.2021.06.007
    </mixed-citation>
   </ref>
   <ref id="scirp.147502-ref7">
    <label>7</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Bourel, G., Duteil, E., Mercier, G. and Roubille, F. (2018) Prise en charge de l’insuffisance cardiaque: Impact d’une organisation innovante sur les réhospitalisations et les coûts, Montpellier, France. Revue d’Épidémiologie et de Santé Publique, 66, S37. &gt;https://doi.org/10.1016/j.respe.2018.01.078
    </mixed-citation>
   </ref>
   <ref id="scirp.147502-ref8">
    <label>8</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     WHO Expert Committee (1993) Rehabilitation after Cardiovascular Diseases, with Special Emphasis on Developing Countries. Report of a WHO Expert Committee. WHO Technical Report Series, 1-122.
    </mixed-citation>
   </ref>
   <ref id="scirp.147502-ref9">
    <label>9</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Tessler, J., Ahmed, I. and Bordoni, B. (2025) Cardiac Rehabilitation. StatPearls. &gt;http://www.ncbi.nlm.nih.gov/books/NBK537196/ 
    </mixed-citation>
   </ref>
   <ref id="scirp.147502-ref10">
    <label>10</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Cyuzuzo, C., Dukuzimana, M.J., Muhire, C., Sheldon Ames, M. and Ngwakongnwi, E. (2025) Challenges to Rehabilitation Services in Sub-Saharan Africa from a User, Health System, and Service Provider Perspective: Scoping Review. JMIR Human Factors, 12, e58841. &gt;https://doi.org/10.2196/58841
    </mixed-citation>
   </ref>
   <ref id="scirp.147502-ref11">
    <label>11</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Iyngkaran, P., Appuhamilage, P.Y., Patabandige, G., Sarathchandra Peru Kandage, P.S., Usmani, W. and Hanna, F. (2024) Barriers to Cardiac Rehabilitation among Patients Diagnosed with Cardiovascular Diseases—A Scoping Review. International Journal of Environmental Research and Public Health, 21, Article 339. &gt;https://doi.org/10.3390/ijerph21030339
    </mixed-citation>
   </ref>
   <ref id="scirp.147502-ref12">
    <label>12</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Nations Unis (2015) Objectif de Développement Durable—Santé et Bienêtre pourtous. Développement Durable. &gt;https://www.un.org/sustainabledevelopment/fr/health/
    </mixed-citation>
   </ref>
   <ref id="scirp.147502-ref13">
    <label>13</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     McDonagh, T.A., Metra, M., Adamo, M., Gardner, R.S., Baumbach, A., Böhm, M., et al. (2021) 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure: Developed by the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) with the Special Contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal, 42, 3599-3726. &gt;https://doi.org/10.1093/eurheartj/ehab368
    </mixed-citation>
   </ref>
   <ref id="scirp.147502-ref14">
    <label>14</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Täger, T., Hanholz, W., Cebola, R., Fröhlich, H., Franke, J., Doesch, A., et al. (2014) Minimal Important Difference for 6-Minute Walk Test Distances among Patients with Chronic Heart Failure. International Journal of Cardiology, 176, 94-98. &gt;https://doi.org/10.1016/j.ijcard.2014.06.035
    </mixed-citation>
   </ref>
   <ref id="scirp.147502-ref15">
    <label>15</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Shoemaker, M.J., Curtis, A.B., Vangsnes, E. and Dickinson, M.G. (2013) Clinically Meaningful Change Estimates for the Six-Minute Walk Test and Daily Activity in Individuals with Chronic Heart Failure. Cardiopulmonary Physical Therapy Journal, 24, 21-29. &gt;https://doi.org/10.1097/01823246-201324030-00004
    </mixed-citation>
   </ref>
   <ref id="scirp.147502-ref16">
    <label>16</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Peduzzi, P., Concato, J., Kemper, E., Holford, T.R. and Feinstein, A.R. (1996) A Simulation Study of the Number of Events per Variable in Logistic Regression Analysis. Journal of Clinical Epidemiology, 49, 1373-1379. &gt;https://doi.org/10.1016/s0895-4356(96)00236-3
    </mixed-citation>
   </ref>
   <ref id="scirp.147502-ref17">
    <label>17</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Sadek, Z., Ramadan, W., Khachfe, H., Ajouz, G., Baydoun, H., Joumaa, W.H., et al. (2021) Comparaison entre entraînement aérobie continu et intermittent pour évaluer le modèle d’exercice optimal chez les patients atteints d’insuffisance cardiaque: Une méta-analyse. Kinésithérapie, la Revue, 21, 37-47. &gt;https://doi.org/10.1016/j.kine.2021.02.008
    </mixed-citation>
   </ref>
   <ref id="scirp.147502-ref18">
    <label>18</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Wisløff, U., Støylen, A., Loennechen, J.P., Bruvold, M., Rognmo, Ø., Haram, P.M., et al. (2007) Superior Cardiovascular Effect of Aerobic Interval Training versus Moderate Continuous Training in Heart Failure Patients: A Randomized Study. Circulation, 115, 3086-3094. &gt;https://doi.org/10.1161/circulationaha.106.675041
    </mixed-citation>
   </ref>
   <ref id="scirp.147502-ref19">
    <label>19</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ellingsen, Ø., Halle, M., Conraads, V., Støylen, A., Dalen, H., Delagardelle, C., et al. (2017) High-intensity Interval Training in Patients with Heart Failure with Reduced Ejection Fraction. Circulation, 135, 839-849. &gt;https://doi.org/10.1161/circulationaha.116.022924
    </mixed-citation>
   </ref>
   <ref id="scirp.147502-ref20">
    <label>20</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Tüner, H., Polat, F., Alıç, E., Kaya, A.N., Çakmak, Ç.B., Coşkun, F., et al. (2025) Effectiveness of Cardiac Rehabilitation in Enhancing Adherence and Improving Clinical Outcomes Post-Acute Coronary Syndrome: A Randomized Controlled Trial. Clinical Cardiology, 48, e70160. &gt;https://doi.org/10.1002/clc.70160
    </mixed-citation>
   </ref>
   <ref id="scirp.147502-ref21">
    <label>21</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Fukuda, T., Kurano, M., Fukumura, K., Yasuda, T., Iida, H., Morita, T., et al. (2013) Cardiac Rehabilitation Increases Exercise Capacity with a Reduction of Oxidative Stress. Korean Circulation Journal, 43, 481-487. &gt;https://doi.org/10.4070/kcj.2013.43.7.481
    </mixed-citation>
   </ref>
   <ref id="scirp.147502-ref22">
    <label>22</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Taty Zau, J.F., Costa Zeferino, R., Sandrine Mota, N., Fernandes Martins, G., Manoel Serra, S., Bonates da Cunha, T., et al. (2017) Exercise through a Cardiac Rehabilitation Program Attenuates Oxidative Stress in Patients Submitted to Coronary Artery Bypass Grafting. Redox Report, 23, 94-99. &gt;https://doi.org/10.1080/13510002.2017.1418191
    </mixed-citation>
   </ref>
   <ref id="scirp.147502-ref23">
    <label>23</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Valaei, K., Taherkhani, S., Arazi, H. and Suzuki, K. (2021) Cardiac Oxidative Stress and the Therapeutic Approaches to the Intake of Antioxidant Supplements and Physical Activity. Nutrients, 13, Article 3483. &gt;https://doi.org/10.3390/nu13103483
    </mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>